Aptevo Therapeutics Inc. (APVO) Financials

APVO Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 24.8 million 12.6 million
2023-09-30 27.1 million 12.4 million
2023-06-30 28.9 million 12.7 million
2023-03-31 35.0 million 11.7 million

APVO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -5.3 million 358000
2023-09-30 -6.2 million 455000
2023-06-30 -4.8 million 465000
2023-03-31 4.6 million 915000

APVO Net Income

No data available :(

APVO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 16.9 million - 5.4 million
2023-09-30 19.1 million - 5.6 million
2023-06-30 21.0 million - 5.7 million
2023-03-31 25.3 million - 5.9 million

APVO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 442458
2023-09-30 12.6 million
2023-06-30 6.5 million
2023-03-31 7.0 million

APVO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 3.5 million 2.8 million -
2023-09-30 - 3.9 million 2.7 million -
2023-06-30 - 5.5 million 2.7 million -
2023-03-31 - 4.2 million 3.6 million -

APVO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 116000
2023-09-30 - 123000
2023-06-30 - 150000
2023-03-31 - 178000

APVO

Price: $0.96

52 week price:
0.68
91.96

Earnings Per Share: -67.07 USD

P/E Ratio: -0.06

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 73389

Ebitda: -9.5 million

Market Capitalization: 2.5 million

Links: